课题基金 / 基金详情

Immune Regulation in the Microenvironment of Oropharyngeal Cancer

Immune Regulation in the Microenvironment of Oropharyngeal Cancer
口咽癌微环境的免疫调节
批准号:
8577165
负责人:
WEIPING ZOU
金额:
$53.47万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-07-01 至 2018-06-30

项目摘要

项目成果

WEIPING ZOU的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Chronic inflammation may contribute to tumor initiation, progression and metastasis. However, the precise mechanism remains to be fully understood. Recent studies indicate that an integral element of tumor biology is the immunologic effects of oncogenic changes, and the quality and state of local inflammation and immune responses are crucial factors controlling carcinogenesis and cancer progression. Mechanisms of immune interactions within the tumor microenvironment are a critical and understudied area of cancer immunology that will impact significantly on the success of immunotherapeutic strategies. IL-17+CD4+ T (Th17) and IL-22+CD4+ T (Th22) cells are found in oropharyngeal cancer. The nature of Th17 and Th22 cells is poorly understood in human oropharyngeal cancer. Our preliminary studies have demonstrated that Th17 and Th22 subsets may be functionally and mechanistically different in the context of oropharygeal cancer. Based on our preliminary data, our specific aims are: Aim 1: To test our hypothesis that Th17 cells have stem cell feature in oropharyngeal cancer Aim 2: To test our hypothesis that Th17 cells epigenetically impact oropharyngeal cancer immunity Aim 3: To test our hypothesis that Th22 cells promote cancer stemness, and Th17/Th22 cells affect patient outcome in oropharyngeal cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CTL-killing capacity and cancer stiffness in cancer immunity and therapy
CTL-killing capacity and cancer stiffness in cancer immunity and therapy
Regulatory T cells in cancer therapy
Regulatory T cells in cancer therapy
海外基金